Interleukin 21 and tyrosine kinase inhibitor combination therapy

Details for Australian Patent Application No. 2007272330 (hide)

Owner ZymoGenetics, Inc.

Inventors Hughes, Steven D.; Hausman, Diana F.; Miller, Dennis M.; Sievers, Eric; Sivakumar, Pallavur V.

Agent Spruson & Ferguson

Pub. Number AU-A-2007272330

PCT Pub. Number WO2008/008981

Priority 60/807,256 13.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 31/404 (2006.01)

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/008981 Priority application(s): WO2008/008981

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272335-Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration

2007272324-Method and apparatus for frequency selective and frequency diversity transmissions in a wireless communication system